Sigma Planning Corp Bio N Tech Se Transaction History

Sigma Planning Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 20, 2022	SELL	$126.25 - $231.85 $103,020 - $189,189	-816 Closed	0 $0
Q4 2021 Feb 02, 2022	SELL	$216.64 - $362.52 $27,946 - $46,765	-129 Reduced 13.65%	816 $210,000
Q3 2021 Oct 28, 2021	SELL	$205.93 - $447.23 $39,126 - $84,973	-190 Reduced 16.74%	945 $258,000
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $128,618 - $274,091	1,135 New	1,135 $254,000

357

38.3M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $27.4B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

Stay updated on Sigma Planning Corp with notifications on news.